Medicine and Dentistry
Mycosis fungoides
77%
Cutaneous T Cell Lymphoma
77%
Melanoma
53%
Neoplasm
43%
Diseases
40%
Cutaneous Lymphoma
34%
Fluorescence in Situ Hybridization
27%
Diagnosis
21%
T Cell
19%
Lymphoproliferative Disease
17%
T-Cell Lymphoma
16%
Spitz Nevus
16%
CD8 Antigen
15%
Nevus
14%
Biopsy Technique
12%
B-Cell Lymphoma
12%
Dermatosis
11%
Blue Nevus
11%
Lupus Erythematosus Panniculitis
9%
Immunohistochemistry
9%
Cicatricial Alopecia
9%
Clonal Variation
8%
Morphology
8%
B Cell
8%
Papule
8%
Lymphocyte
8%
Clinical Trial
7%
Lymphomatoid Papulosis
7%
Cytotoxic T-Cell
7%
Cancer Treatment
7%
Non-Hodgkin Lymphoma
7%
Metastatic Melanoma
7%
MALT Lymphoma
7%
Malignant Neoplasm
7%
Pediatrics
6%
Cutaneous Melanoma
6%
Sezary Syndrome
6%
Immunosuppressive Treatment
6%
Disease Course
6%
Lymphoma Cell
6%
Pruritus
6%
Pathologist
6%
T Lymphocyte Receptor
6%
Leg
5%
Skin Biopsy
5%
Immunophenotyping
5%
Recurrent Disease
5%
Gamma Delta T-Cell
5%
Dermatology
5%
Keyphrases
Cutaneous T-cell Lymphoma
100%
Mycosis Fungoides
85%
Melanoma
34%
Cutaneous Lymphoma
30%
Fluorescence in Situ Hybridization
25%
Primary Cutaneous
18%
Histopathological Features
17%
Lymphoproliferative Disorders
13%
T-cell Lymphoma
13%
Melanocytic Nevus
13%
T Cells
12%
Nevus
11%
Advanced Stage
11%
Epidermis
10%
Single Institution
10%
Lymphoma
10%
Spitzoid Melanoma
10%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
10%
Metastatic Melanoma
10%
Spitz Tumor
9%
Malignant Melanoma
9%
CD30+ Lymphoproliferative Disorders
9%
Primary Cutaneous Lymphoma
9%
Tumor
8%
Sézary Syndrome
8%
Clinical Presentation
8%
Molecular Features
8%
Plaque
8%
United States
8%
Histologic
8%
Lymphomatoid Papulosis
7%
Clinical Features
7%
Cancer Treatment
7%
European Organizations
7%
Primary Cutaneous T-cell Lymphoma
7%
Primary Cutaneous B-cell Lymphoma
7%
Clinical Trials
7%
Dermatologist
7%
Spitz Nevus
7%
Complete Remission
7%
Cicatricial Alopecia
7%
Non-Hodgkin Lymphoma
6%
Keratinocytes
6%
Pathologist
6%
CD8+
6%
Immunohistochemistry
6%
Blue Nevus
6%
Dermatopathology
6%
World Health Organization Classification
6%
Treatment Strategy
6%